Abstract
In a double-blind trial tranexamic acid (Cyclokapron) 1 g. four times a day for the first four days of menstruation, significantly decreased menstrual blood loss in women with menorrhagia for which no organic cause had been found. No difference in side-effects was noted between the active and placebo treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hallberg L., Högdahl A. M., Nilsson L., Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351. doi: 10.3109/00016346609158455. [DOI] [PubMed] [Google Scholar]
- Holt J. M., Mayet F. G., Warner G. T., Callender S. T. Measurement of blood loss by means of a whole-body counter. Br Med J. 1967 Oct 14;4(5571):86–88. doi: 10.1136/bmj.4.5571.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NILSSON I. M., BJOERKMAN S. E. EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. Acta Med Scand. 1965 Apr;177:445–457. [PubMed] [Google Scholar]
- Nilsson L., Rybo G. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation. Acta Obstet Gynecol Scand. 1965;44(3):467–473. doi: 10.3109/00016346509155880. [DOI] [PubMed] [Google Scholar]
- Vermylen J., Verhaegen-Declercq M. L., Verstraete M., Fierens F. A double blind study of the effect of tranexamic acid in essential menorrhagia. Thromb Diath Haemorrh. 1968 Dec 31;20(3):583–587. [PubMed] [Google Scholar]
- Warner G. T., Oliver R. A whole-body counter for clinical measurements utilizing the 'shadow shield' technique. Phys Med Biol. 1966 Jan;11(1):83–94. doi: 10.1088/0031-9155/11/1/307. [DOI] [PubMed] [Google Scholar]